Follow
Michael Lydeamore
Michael Lydeamore
Lecturer, Department of Econometrics and Business Statistics, Monash University
Verified email at monash.edu
Title
Cited by
Cited by
Year
Risk mapping for COVID-19 outbreaks in Australia using mobility data
C Zachreson, L Mitchell, MJ Lydeamore, N Rebuli, M Tomko, N Geard
Journal of the Royal Society Interface 18 (174), 20200657, 2021
452021
Understanding how Victoria, Australia gained control of its second COVID-19 wave
JM Trauer, MJ Lydeamore, GW Dalton, D Pilcher, MT Meehan, ...
Nature Communications 12 (1), 6266, 2021
292021
A biological model of scabies infection dynamics and treatment informs mass drug administration strategies to increase the likelihood of elimination
MJ Lydeamore, PT Campbell, DG Regan, SYC Tong, RM Andrews, ...
Mathematical biosciences 309, 163-173, 2019
222019
Indigenous Australian household structure: a simple data collection tool and implications for close contact transmission of communicable diseases
T Vino, GR Singh, B Davison, PT Campbell, MJ Lydeamore, A Robinson, ...
PeerJ 5, e3958, 2017
212017
High burden of infectious disease and antibiotic use in early life in Australian Aboriginal communities
W Cuningham, J McVernon, MJ Lydeamore, RM Andrews, J Carapetis, ...
Australian and New Zealand journal of public health 43 (2), 149-155, 2019
152019
Calculation of the age of the first infection for skin sores and scabies in five remote communities in northern Australia
MJ Lydeamore, PT Campbell, W Cuningham, RM Andrews, T Kearns, ...
Epidemiology & Infection 146 (9), 1194-1201, 2018
152018
Burden of five healthcare associated infections in Australia
MJ Lydeamore, BG Mitchell, T Bucknall, AC Cheng, PL Russo, ...
Antimicrobial Resistance & Infection Control 11 (1), 1-7, 2022
132022
COVID-19 in low-tolerance border quarantine systems: Impact of the Delta variant of SARS-CoV-2
C Zachreson, FM Shearer, DJ Price, MJ Lydeamore, J McVernon, ...
Science Advances 8 (14), eabm3624, 2022
102022
Analyses to predict the efficacy and waning of vaccines and previous infection against transmission and clinical outcomes of SARS-CoV-2 variants
N Golding, M Lydeamore
See https://github. com/goldingn/neuts2efficacy (accessed 5 April 2022), 2022
92022
Bringing evidence from press release to the clinic in the era of COVID-19
JH McMahon, MJ Lydeamore, AJ Stewardson
Journal of Antimicrobial Chemotherapy, 2020
92020
Doherty institute modelling report for national cabinet
J McVernon, D Price, T Campbell, N Golding, CM Baker, J Walker, ...
Melbourne: The Peter Doherty Institute for Infection and Immunity, 2021
62021
Estimation of the force of infection and infectious period of skin sores in remote Australian communities using interval-censored data
MJ Lydeamore, PT Campbell, DJ Price, Y Wu, AJ Marcato, W Cuningham, ...
PLoS Computational Biology 16 (10), e1007838, 2020
62020
Analyses to predict the efficacy and waning of vaccines and previous infection against transmission and clinical outcomes of SARS-CoV-2 variants.[accessed 22 Feb 2022]
N Golding, M Lydeamore
Github repository. URL: https://github. com/goldingn/neuts2efficacy, 0
5
Estimating the impact of test-trace-isolate-quarantine systems on SARS-CoV-2 transmission in Australia
FM Shearer, JM McCaw, G Ryan, T Hao, NJ Tierney, M Lydeamore, ...
medRxiv, 2023.01. 10.23284209, 2023
42023
Choice of antiviral allocation scheme for pandemic influenza depends on strain transmissibility, delivery delay and stockpile size
M Lydeamore, N Bean, AJ Black, JV Ross
Bulletin of mathematical biology 78, 293-321, 2016
32016
COVID-19 vaccine coverage targets to inform reopening plans in a low incidence setting
E Conway, CR Walker, C Baker, MJ Lydeamore, GE Ryan, T Campbell, ...
Proceedings of the Royal Society B 290 (2005), 20231437, 2023
22023
Mechanistic and Statistical Models of Skin Disease Transmission
MJ Lydeamore
The University of Melbourne, 2018
22018
The incidence of nosocomial bloodstream infection and urinary tract infection in Australian hospitals before and during the COVID-19 pandemic: an interrupted time series study
BG Mitchell, AJ Stewardson, L Kerr, JK Ferguson, S Curtis, L Busija, ...
Antimicrobial Resistance & Infection Control 12 (1), 61, 2023
12023
Modelling the impact of hybrid immunity on future COVID-19 epidemic waves
TP Le, IR Abell, EJ Conway, PT Campbell, AB Hogan, MJ Lydeamore, ...
medRxiv, 2023.03. 12.23287174, 2023
12023
COVID-19 in low-tolerance border quarantine systems: impact of the Delta variant of SARS-CoV-2 (preprint)
C Zachreson, FM Shearer, DJ Price, MJ Lydeamore, J McVernon, ...
12021
The system can't perform the operation now. Try again later.
Articles 1–20